These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23151457)

  • 21. Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.
    Lee JY; Badeau RM; Mulya A; Boudyguina E; Gebre AK; Smith TL; Parks JS
    J Lipid Res; 2007 May; 48(5):1052-61. PubMed ID: 17272829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro.
    Asada S; Kuroda M; Aoyagi Y; Bujo H; Tanaka S; Konno S; Tanio M; Ishii I; Aso M; Saito Y
    Mol Genet Metab; 2011 Feb; 102(2):229-31. PubMed ID: 21074466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lecithin cholesterol acyltransferase deficiency protects from diet-induced insulin resistance and obesity--novel insights from mouse models.
    Ng DS
    Vitam Horm; 2013; 91():259-70. PubMed ID: 23374720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J).
    Mehrabian M; Castellani LW; Wen PZ; Wong J; Rithaporn T; Hama SY; Hough GP; Johnson D; Albers JJ; Mottino GA; Frank JS; Navab M; Fogelman AM; Lusis AJ
    J Lipid Res; 2000 Dec; 41(12):1936-46. PubMed ID: 11108726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways.
    Li L; Hossain MA; Sadat S; Hager L; Liu L; Tam L; Schroer S; Huogen L; Fantus IG; Connelly PW; Woo M; Ng DS
    J Biol Chem; 2011 May; 286(20):17809-20. PubMed ID: 21454561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation network analysis shows divergent effects of a long-term, high-fat diet and exercise on early stage osteoarthritis phenotypes in mice.
    Griffin TM; Batushansky A; Hudson J; Lopes EBP
    J Sport Health Sci; 2020 Mar; 9(2):119-131. PubMed ID: 32099720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Artery; 1997; 22(4):182-205. PubMed ID: 9576025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids.
    McManus DC; Scott BR; Frank PG; Franklin V; Schultz JR; Marcel YL
    J Biol Chem; 2000 Feb; 275(7):5043-51. PubMed ID: 10671546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
    Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
    J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.
    Wong L; Curtiss LK; Huang J; Mann CJ; Maldonado B; Roheim PS
    J Clin Invest; 1992 Dec; 90(6):2370-5. PubMed ID: 1281832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of altered apolipoprotein A-I structure on plasma HDL concentration.
    Sorci-Thomas MG; Thomas MJ
    Trends Cardiovasc Med; 2002 Apr; 12(3):121-8. PubMed ID: 12007737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable cartilage degradation in mice with diet-induced metabolic dysfunction: food for thought.
    Kozijn AE; Gierman LM; van der Ham F; Mulder P; Morrison MC; Kühnast S; van der Heijden RA; Stavro PM; van Koppen A; Pieterman EJ; van den Hoek AM; Kleemann R; Princen HMG; Mastbergen SC; Lafeber FPJG; Zuurmond AM; Bobeldijk I; Weinans H; Stoop R
    Osteoarthritis Cartilage; 2018 Jan; 26(1):95-107. PubMed ID: 29074298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.